SalioGen Therapeutics rallies $115m Series B

SalioGen Therapeutics, a biotechnology company, has raised $115 million in Series B financing.

SalioGen Therapeutics, a biotechnology company, has raised $115 million in Series B financing. GordonMD Global Investments and EPIQ Capital Group led the round.

Source: Press Release